-
公开(公告)号:US10471175B2
公开(公告)日:2019-11-12
申请号:US15134764
申请日:2016-04-21
Applicant: MÖLNLYCKE HEALTH CARE AB
Inventor: Michael Sander , Harald Potzschke
IPC: A61L26/00 , A61K38/42 , A61M35/00 , C07K14/805 , A61M1/34
Abstract: A method for preparing a composition for external treatment of wounds includes charging at least 90% of the oxygen binding sites of hemoglobin with carbon monoxide during or after isolation from its natural environment. The method further includes adding at least one further ingredient selected from the group consisting of electrolyte(s), preservative(s), stabilizer(s), anti-flocculant(s), anticoagulant(s), pH buffering agent(s), solvent(s), antioxidant(s), film-forming agent(s) and crosslinking agent(s). The method can further include packaging the composition, such as in an aerosol can.
-
公开(公告)号:US11116868B2
公开(公告)日:2021-09-14
申请号:US16835662
申请日:2020-03-31
Applicant: MÖLNLYCKE HEALTH CARE AB
Inventor: Michael Sander , Harald Potzschke
IPC: A61L26/00 , A61M1/34 , A61K38/42 , A61M35/00 , C07K14/805
Abstract: The present invention refers to a composition, comprising hemoglobin or myoglobin, wherein in at least 40% of said hemoglobin or myoglobin the oxygen binding site is charged by a non-O2 ligand, and at least one further ingredient, a method for preparing said composition and the use of hemoglobin or myoglobin charged with a non-oxygen ligand for external treatment of wounds.
-
公开(公告)号:US20200230285A1
公开(公告)日:2020-07-23
申请号:US16835662
申请日:2020-03-31
Applicant: MÖLNLYCKE HEALTH CARE AB
Inventor: Michael Sander , Harald Potzschke
IPC: A61L26/00 , A61M1/34 , A61K38/42 , A61M35/00 , C07K14/805
Abstract: The present invention refers to a composition, comprising hemoglobin or myoglobin, wherein in at least 40% of said hemoglobin or myoglobin the oxygen binding site is charged by a non-O2 ligand, and at least one further ingredient, a method for preparing said composition and the use of hemoglobin or myoglobin charged with a non-oxygen ligand for external treatment of wounds.
-
-